TUTI-16 (1.0 mg)

BIOLOGICAL2 trials

Sponsors

Thymon, LLC

Conditions

HIV Infections

Phase 1

Clinical Study of TUTI-16 in HIV-1 Infected and Uninfected Subjects

CompletedNCT01144026

Thymon, LLCHIV Infections

Start: 2010-09-30End: 2011-04-30Updated: 2013-01-18

Clinical Study of TUTI-16 in Asymptomatic HIV-1 Infected Subjects (THYMON-11001)

CompletedNCT01335191

Thymon, LLCHIV Infections

Start: 2011-06-30End: 2012-06-30Updated: 2013-02-15